Literature DB >> 32834539

Esther Veronika Wenzel1, Giulio Russo1, Stefan Dübel1,2.   

Abstract

Today, recombinant antibodies can replace animal-derived primary antibodies in almost all applications. Due to their monoclonal origin and always known sequence, they offer optimal reproducibility. In contrast, almost all secondary antibodies are still made from animal sera. Multiclonal antibodies made by animal-free recombinant methods here offer a higher quality replacement for serum-derived secondary antibodies. © Die Autoren 2020.

Entities:  

Year:  2020        PMID: 32834539      PMCID: PMC7318723          DOI: 10.1007/s12268-020-1401-7

Source DB:  PubMed          Journal:  Biospektrum (Heidelb)        ISSN: 0947-0867


  6 in total

1.  Reproducibility: Standardize antibodies used in research.

Authors:  Andrew Bradbury; Andreas Plückthun
Journal:  Nature       Date:  2015-02-05       Impact factor: 49.962

2.  Reproducibility: bypass animals for antibody production.

Authors:  Alison C Gray; Andrew Bradbury; Stefan Dübel; Achim Knappik; Andreas Plückthun; Carl A K Borrebaeck
Journal:  Nature       Date:  2020-05       Impact factor: 49.962

3.  Sequence defined antibodies improve the detection of cadherin 2 (N-cadherin) during zebrafish development.

Authors:  Giulio Russo; Ulrike Theisen; Wieland Fahr; Saskia Helmsing; Michael Hust; Reinhard W Köster; Stefan Dübel
Journal:  N Biotechnol       Date:  2017-12-28       Impact factor: 5.079

4. 

Authors:  Stefan Dübel; Michael Hust; André Frenzel; Thomas Schirrmann
Journal:  Biospektrum (Heidelb)       Date:  2020-06-26

Review 5.  Designing Human Antibodies by Phage Display.

Authors:  André Frenzel; Jonas Kügler; Saskia Helmsing; Doris Meier; Thomas Schirrmann; Michael Hust; Stefan Dübel
Journal:  Transfus Med Hemother       Date:  2017-08-25       Impact factor: 3.747

6.  When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions.

Authors:  Andrew R M Bradbury; Nathan D Trinklein; Holger Thie; Ian C Wilkinson; Atul K Tandon; Stephen Anderson; Catherine L Bladen; Brittany Jones; Shelley Force Aldred; Marco Bestagno; Oscar Burrone; Jennifer Maynard; Fortunato Ferrara; James S Trimmer; Janina Görnemann; Jacob Glanville; Philipp Wolf; Andre Frenzel; Julin Wong; Xin Yu Koh; Hui-Yan Eng; David Lane; Marie-Paule Lefranc; Mike Clark; Stefan Dübel
Journal:  MAbs       Date:  2018-03-29       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.